moderate obstructive lung disease with significant response to bronchodilator, a severe obstructive sleep apnoea on polysomnography and a hgb of 212 and hct of 0.69 on CBC. He was immediately referred to a haematologist and underwent phlebotomy. He had immediate relief of symptoms and hgb decreased to 177, hct 55. He was also started on low dose ICS/LABA and Doxofylline and CPAP with PS of 13 and oxygen of 2 L per minute. On follow up, patient feels great, 02 sat of 96% at room air, normal PFT and sleep study showed moderate sleep apnoea. He was advised to continue CPAP and inhaler.
Background and Aims: The purpose of this study was to assess CPAP adherence in Changsha (a representative Chinese city) adults with newly diagnosed OSAHS and assess the influential factors for CPAP adherence in this group.
Methods: A prospective longitudinal study was ongoing at the Second Xiangya Hospital and the Third Xiangya Hospital, CSU, Changsha, China. Consecutive 156 newly diagnosed OSAHS patients (138 males and 18 female, 118 severe and 38 moderate patients) were recruited for study participation. Following the diagnostic PSG, participants completed risk screening questionnaires including The Epworth Sleepiness Scale (ESS), The Health Literacy Screening Questionnaire (HLS). The Selfefficacy Measure in Sleep Apnoea (SEMSA), Sleep Apnoea Quality of Life Index (SAQLI). Participants completed a full-night, in-laboratory CPAP titration with PSG. After the CPAP titration, participants completed The Visual Analogue Scale (VAS) questionnaire about treatment. Participants returned to the sleep center for a scheduled research visit after 30 days of home CPAP treatment. The SPSS 13.0 analysis software was used.
Results: Only 55.8% patients (87 patients, including 80 severe and 7 moderate patients, 78 males and 9 female) had good CPAP adherence. There are difference between good and poor adherence patients in age, ESS, AHI, the lowest SaO 2 , VAS, HLS and SEMSA ( Methods: Studies investigating the OSA in patients with RBD were systematically retrieved by two independent researchers from MEDLINE, EMBASE and Cochrane Library from inception date to January 2018. The main outcomes included sleep efficiency, subjective sleepiness and neurocognitive function. The Subjective sleepiness was evaluated with Epworth Sleepiness Scale (ESS) while neurocognitive function was evaluated by Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). MMSE was converted to MoCA score to facilitate analysis. The effect of OSA was analyzed by random-effects metaanalysis and expressed as mean differences and 95% confidence intervals (95% CI). The heterogeneity was evaluated with I 2 .
Results: The meta-analysis included 5 studies comprising of 373 RBD patients including 284 patients with OSA (RBD-OSA) and 89 without OSA (RBD-NOSA). The mean age was 62.3 y/o, 79.9% were male, and mean body mass index was 26.5 kg/m 2 . The studies were homogeneous for all three outcomes (I 2 from 0 to 26%). The RBD-OSA had similar sleep efficiency (mean -2.31%; 95% CI -8.80 to 4.17; P = 0.26), ESS (mean −2.03, 95% CI −4.47 to 0.40, P = 0.58), and MoCA score (mean 0.15, 95% CI −3.57, 3.87; P = 0.45) with RBD-NOSA. Methods: This retrospective study included total of 306 women, both indigenous and non-indigenous Australian, who underwent diagnostic sleep study for suspected obstructive sleep apnoea at the Darwin Respiratory and Sleep Health from January to December 2015. All subjects underwent anthropometric measurements (height, weight, BMI, neck circumference), questionnaire for risk assessment of OSA (hypertension, heart disease, diabetes mellitus, depression, use of anti-depressants, smoking and alcohol use) and Epworth Sleepiness Score before the diagnostic sleep study. We used American Academy of Sleep Medicine guideline for severity assessment of OSA.
Results: A total of 306 women underwent sleep study; diagnosis of obstructive sleep apnoea was made in 102 (33%), which comprise 21 indigenous women (20%) and 81 non-indigenous women (80%). Severe daytime sleepiness with ESS more than 9 was reported by 56% of OSA diagnosed women. The mean age of all women who were diagnosed with sleep apnoea was 52 (min = 21.1, max = 80.1, SD = 13.3), comprising mean age 46.9 (min = 21.1, max = 75, SD = 13.9) for indigenous and 54(min = 42, max = 79, SD = 14.6) for non-indigenous. Mean BMI of all OSA patients was 37. For indigenous patients with OSA, mean BMI is 37 and that of nonindigenous cohort was 36. Mean neck circumference of indigenous OSA patients was 42 cm whilst that of non-indigenous women was 38.8 cm. Mean AHI of all OSA patients was 37(min = 4.8, max = 140, SD = 25.6). Indigenous women scored higher mean AHI 42.2(min = 12.1, max = 130) compared to mean AHI 36.3(min = 4.8, max = 140) of non-indigenous women.
Conclusion:
Although lower proportion of indigenous women are diagnosed with obstructive sleep apnoea, the disease is more severe in them, associated with higher BMI and thicker neck circumference. Background and Aims: Deventilation dyspnoea (DD) following cessation of nocturnal non-invasive ventilation (NIV) has been described in individuals with severely impaired lung function. However, the pathophysiology is less well-understood and diagnosis is often challenging.
Methods:
We describe the use of a wireless wearable ward-based continuous pulse oximetry and vital signs monitoring device (ViSi Mobile System, Sotera Wireless) in a case of DD.
Results: The patient was a frail elderly woman who presented with progressive dyspnoea. Significant past medical history included kyphoscoliosis with chronic hypercapnic respiratory failure on nocturnal NIV (6-7 h per night) for the 13 years preceding current admission. Clinical examination revealed kyphoscoliosis and signs of cor pulmonale. Chest imaging showed pulmonary infiltrates and bilateral pleural effusions consistent with fluid overload. This resolved with diuresis and pleural drainage. However, despite euvolemia, persistent dyspnea was observed following removal of NIV in the morning. Continuous pulse oximetry revealed mean (standard deviation) oxygen saturation (SpO 2 ) of 95.7 (2.3)% and 92.4 (2.1)% during NIV and when off NIV respectively; the findings correlated with arterial blood gas analysis showing partial pressure of carbon dioxide (PaCO 2 ) 43 mmHg during NIV and hypercarbia (PaCO 2 59) when off NIV. There was a sharp decline in SpO 2 during removal of NIV in the morning (see Figure -Arrow ). Alveolar-arterial oxygen gradient was normal throughout, which suggested no significant parenchymal disease or ventilation-perfusion mismatch. We suspected a component of respiratory muscle weakness but the patient was too weak to perform pulmonary function testing. The duration of NIV usage was lengthened and a small dose of opiate was administered in the morning following removal of NIV, which led to symptomatic improvement. 
Conclusion
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Background and Aims: Mindful breathing has been practised in recent decades and there is a lack of study for it as a nonpharmacological method in improving dyspnea. This study was to assess the efficacy of mindful breathing in improvement of dyspnea score, oxygen saturation and respiratory rate in patients with lung diseases.
Methods: Sixty three inward patients, diagnosed with lung cancer, acute exacerbation of bronchial asthma (AEBA) or acute exacerbation of chronic obstructive pulmonary disease (AECOPD), were recruited and assigned randomly into intervention and control groups. They reported their dyspnea score according to Modified Borg Dyspnea scale while oxygen saturation and respiratory rate were measured. The parameters were
